Related Experiment Video
Updated: Jun 1, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing
Fang Zheng1, Yi-Ji Liao, Mu-Yan Cai
1The State Key Laboratory of Oncology in South China, Sun Yat-Sen University, Guangzhou, China.
Gut
|June 16, 2011
Summary
MicroRNA-124 (miR-124) is frequently reduced in hepatocellular carcinoma (HCC), inhibiting cancer cell invasion and metastasis. This study reveals miR-124
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) exhibits altered microRNA (miRNA) expression profiles, with miR-124 showing deregulation.
- Understanding the role of miR-124 in HCC pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression status of miR-124 in HCC.
- To elucidate the mechanisms by which miR-124 influences HCC progression.
- To assess the potential of miR-124 as a prognostic marker and therapeutic target.
Main Methods:
- Real-time PCR was used to quantify miR-124 expression in HCC cell lines and tissues.
- In vitro and in vivo functional assays were performed to evaluate the effects of miR-124.
- Luciferase reporter assays confirmed direct targeting of ROCK2 and EZH2 by miR-124.
Main Results:
- miR-124 expression was significantly reduced in HCC cells and tissues, correlating with aggressive phenotypes and poor prognosis.
- Overexpression of miR-124 inhibited HCC cell motility, invasion, and metastasis in vitro and in vivo.
- miR-124 suppressed epithelial-mesenchymal transition and directly targeted ROCK2 and EZH2, reducing their expression.
Conclusions:
- miR-124 plays a critical role in suppressing HCC invasion and metastasis by targeting ROCK2 and EZH2.
- These findings highlight miR-124's potential as a biomarker for HCC prognosis and a therapeutic agent.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...